chartexchange

AYTU
AYTU BioPharma, Inc. Common Stock
stockNASDAQ

Market OpenNov 17, 2026 1:38:17 PM EST
2.65USD+45.879%(+0.83)3,681,413
Pre-marketNov 17, 2026 9:29:30 AM EST
2.6697USD+46.687%(+0.8497)
2.6500Bid2.6600Ask0.0100Spread
Loading…
Loading…
Healthcare
Drug Manufacturers-Specialty & Generic
HQ
Englewood, CO, USA
Previous Close
$1.82
Beta
0.65
52-Week High
$3.07 2026-01-05
52-Week Low
$1.75 2026-11-16
SMA 50
$2.00
SMA 200
$2.27
Avg. Vol 10D
172,695
Avg. Vol 30D
72,654
Avg. Vol 90D
48,045
Relative Vol
36.78
9.97M
17.8500%
Jan 6, 2023 · 1-for-20 (reverse)
AYTU Profile

aytu bioscience is a specialty healthcare company focused on developing and commercializing novel products in the field of urology. aytu is initially concentrating on prostate cancer, male premature ejaculation and male infertility and plans to expand into other urological indications for which there are significant medical needs. the company currently markets prostascint®, an fda-approved radioimaging agent indicated to detect prostate specific membrane antigen (psma) in the assessment and staging of prostate cancer. the company's most advanced therapeutic is zertane™, an oral therapeutic entering phase 3 clinical studies in the united states as an as needed treatment for premature ejaculation (pe). aytu is also conducting clinical trials with the company's mioxsys™ system as a novel, point-of-care diagnostic system with the potential to become a standard of care in the diagnosis and management of male infertility.

AYTU Performance
PeriodPriceDateChangeBeta
1W1.812026-11-10+46.69%-0.672
1M2.042026-10-16+30.15%0.454
3M2.362026-08-17+12.50%0.508
6M2.102026-05-18+26.43%0.486
1Y1.982025-11-17+34.09%0.651
2Y1.602024-11-18+65.94%—
5Y42.602021-11-17-93.77%0.849
AYTU Stock Summary

AYTU BioPharma, Inc. Common Stock (NASDAQ:AYTU) stock price today is $2.66, and today's volume is 2,671,944. AYTU is up 45.879% today. The 30 day average volume is 72,654. AYTU market cap is $28.85M with 10.87M shares outstanding.